ASX - By Stock
|
MSB |
Re:
Ann: Pause in Trading
|
|
Techinvestor
|
226 |
82K |
2 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
226
|
82K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Pause in Trading
|
|
Techinvestor
|
226 |
82K |
3 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
226
|
82K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Techinvestor
|
10K |
3.0M |
6 |
07/02/24 |
07/02/24 |
ASX - By Stock
|
10K
|
3.0M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Techinvestor
|
10K |
3.0M |
5 |
07/02/24 |
07/02/24 |
ASX - By Stock
|
10K
|
3.0M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Techinvestor
|
10K |
3.0M |
5 |
07/02/24 |
07/02/24 |
ASX - By Stock
|
10K
|
3.0M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Techinvestor
|
10K |
3.0M |
9 |
28/01/24 |
28/01/24 |
ASX - By Stock
|
10K
|
3.0M
|
9
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Techinvestor
|
10K |
3.0M |
7 |
27/01/24 |
27/01/24 |
ASX - By Stock
|
10K
|
3.0M
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Grants Rare Pediatric Disease Designation for Revascor
|
|
Techinvestor
|
380 |
130K |
6 |
24/01/24 |
24/01/24 |
ASX - By Stock
|
380
|
130K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Grants Rare Pediatric Disease Designation for Revascor
|
|
Techinvestor
|
380 |
130K |
13 |
19/01/24 |
19/01/24 |
ASX - By Stock
|
380
|
130K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Techinvestor
|
10K |
3.0M |
12 |
13/01/24 |
13/01/24 |
ASX - By Stock
|
10K
|
3.0M
|
12
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Techinvestor
|
10K |
3.0M |
4 |
12/01/24 |
12/01/24 |
ASX - By Stock
|
10K
|
3.0M
|
4
|
|
ASX - By Stock
|
MSB |
Re:
CEO Itescu needs to go
|
|
Techinvestor
|
907 |
285K |
3 |
24/08/23 |
24/08/23 |
ASX - By Stock
|
907
|
285K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
CEO Itescu needs to go
|
|
Techinvestor
|
907 |
285K |
1 |
24/08/23 |
24/08/23 |
ASX - By Stock
|
907
|
285K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
CEO Itescu needs to go
|
|
Techinvestor
|
907 |
285K |
2 |
24/08/23 |
24/08/23 |
ASX - By Stock
|
907
|
285K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
CEO Itescu needs to go
|
|
Techinvestor
|
907 |
285K |
8 |
24/08/23 |
24/08/23 |
ASX - By Stock
|
907
|
285K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Techinvestor
|
88 |
28K |
1 |
10/08/23 |
10/08/23 |
ASX - By Stock
|
88
|
28K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Techinvestor
|
88 |
28K |
1 |
10/08/23 |
10/08/23 |
ASX - By Stock
|
88
|
28K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
MSB becomes a take over target then US company gets approval for all the hard work?
|
|
Techinvestor
|
5 |
1.7K |
2 |
10/08/23 |
10/08/23 |
ASX - By Stock
|
5
|
1.7K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
SUCKERS!
|
|
Techinvestor
|
48 |
16K |
3 |
10/08/23 |
10/08/23 |
ASX - By Stock
|
48
|
16K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Techinvestor
|
88 |
28K |
1 |
10/08/23 |
10/08/23 |
ASX - By Stock
|
88
|
28K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Why a trial?
|
|
Techinvestor
|
107 |
35K |
9 |
10/08/23 |
10/08/23 |
ASX - By Stock
|
107
|
35K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Techinvestor
|
88 |
28K |
1 |
09/08/23 |
09/08/23 |
ASX - By Stock
|
88
|
28K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Techinvestor
|
88 |
28K |
8 |
09/08/23 |
09/08/23 |
ASX - By Stock
|
88
|
28K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
CEO Itescu needs to go
|
|
Techinvestor
|
907 |
285K |
1 |
09/08/23 |
09/08/23 |
ASX - By Stock
|
907
|
285K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Techinvestor
|
88 |
28K |
1 |
09/08/23 |
09/08/23 |
ASX - By Stock
|
88
|
28K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
Techinvestor
|
88 |
28K |
3 |
09/08/23 |
09/08/23 |
ASX - By Stock
|
88
|
28K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Why a trial?
|
|
Techinvestor
|
107 |
35K |
40 |
09/08/23 |
09/08/23 |
ASX - By Stock
|
107
|
35K
|
40
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
Techinvestor
|
1.0K |
400K |
6 |
09/08/23 |
09/08/23 |
ASX - By Stock
|
1.0K
|
400K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
CEO Itescu needs to go
|
|
Techinvestor
|
907 |
285K |
3 |
08/08/23 |
08/08/23 |
ASX - By Stock
|
907
|
285K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
Techinvestor
|
1.0K |
400K |
4 |
06/08/23 |
06/08/23 |
ASX - By Stock
|
1.0K
|
400K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
CEO Itescu needs to go
|
|
Techinvestor
|
907 |
285K |
10 |
06/08/23 |
06/08/23 |
ASX - By Stock
|
907
|
285K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
CEO Itescu needs to go
|
|
Techinvestor
|
907 |
285K |
0 |
06/08/23 |
06/08/23 |
ASX - By Stock
|
907
|
285K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
CEO Itescu needs to go
|
|
Techinvestor
|
907 |
285K |
22 |
06/08/23 |
06/08/23 |
ASX - By Stock
|
907
|
285K
|
22
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
Techinvestor
|
1.0K |
400K |
9 |
05/08/23 |
05/08/23 |
ASX - By Stock
|
1.0K
|
400K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
Techinvestor
|
1.0K |
400K |
11 |
05/08/23 |
05/08/23 |
ASX - By Stock
|
1.0K
|
400K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Reports Q3 Financial Results and Operational Highlights
|
|
Techinvestor
|
362 |
114K |
8 |
27/05/23 |
27/05/23 |
ASX - By Stock
|
362
|
114K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
Techinvestor
|
3.4K |
1.2M |
3 |
18/05/23 |
18/05/23 |
ASX - By Stock
|
3.4K
|
1.2M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
Techinvestor
|
3.4K |
1.2M |
5 |
18/05/23 |
18/05/23 |
ASX - By Stock
|
3.4K
|
1.2M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
Techinvestor
|
3.4K |
1.2M |
13 |
18/05/23 |
18/05/23 |
ASX - By Stock
|
3.4K
|
1.2M
|
13
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on Novartis Agreement
|
|
Techinvestor
|
850 |
252K |
8 |
27/04/23 |
27/04/23 |
ASX - By Stock
|
850
|
252K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on Novartis Agreement
|
|
Techinvestor
|
850 |
252K |
10 |
27/04/23 |
27/04/23 |
ASX - By Stock
|
850
|
252K
|
10
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
Techinvestor
|
555 |
268K |
19 |
12/04/23 |
12/04/23 |
ASX - By Stock
|
555
|
268K
|
19
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
Techinvestor
|
555 |
268K |
11 |
12/04/23 |
12/04/23 |
ASX - By Stock
|
555
|
268K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
Techinvestor
|
555 |
268K |
8 |
11/04/23 |
11/04/23 |
ASX - By Stock
|
555
|
268K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
Techinvestor
|
555 |
268K |
16 |
11/04/23 |
11/04/23 |
ASX - By Stock
|
555
|
268K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
Techinvestor
|
1.0K |
392K |
2 |
10/04/23 |
10/04/23 |
ASX - By Stock
|
1.0K
|
392K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
Techinvestor
|
1.0K |
392K |
7 |
10/04/23 |
10/04/23 |
ASX - By Stock
|
1.0K
|
392K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
Techinvestor
|
1.0K |
392K |
20 |
06/04/23 |
06/04/23 |
ASX - By Stock
|
1.0K
|
392K
|
20
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Schedules GvHD Pre-License Manufacturing Inspection
|
|
Techinvestor
|
275 |
111K |
7 |
23/03/23 |
23/03/23 |
ASX - By Stock
|
275
|
111K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Schedules GvHD Pre-License Manufacturing Inspection
|
|
Techinvestor
|
275 |
111K |
6 |
23/03/23 |
23/03/23 |
ASX - By Stock
|
275
|
111K
|
6
|
|